A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä
Diet- and microbiota-related metabolite, 5-aminovaleric acid betaine (5-AVAB), in health and disease
Tekijät: Haikonen Retu, Kärkkäinen Olli, Koistinen Ville, Hanhineva Kati
Kustantaja: Elsevier Inc.
Julkaisuvuosi: 2022
Journal: Trends in Endocrinology and Metabolism
Tietokannassa oleva lehden nimi: Trends in Endocrinology and Metabolism
Vuosikerta: 33
Numero: 7
Aloitussivu: 463
Lopetussivu: 480
DOI: https://doi.org/10.1016/j.tem.2022.04.004
Verkko-osoite: https://doi.org/10.1016/j.tem.2022.04.004
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/175509263
5-Aminovaleric acid betaine (5-AVAB) is a trimethylated compound associated with the gut microbiota, potentially produced endogenously, and related to the dietary intake of certain foods such as whole grains. 5-AVAB accumulates within the metabolically active tissues and has been typically found in higher concentrations in the heart, muscle, and brown adipose tissue. Furthermore, 5-AVAB has been associated with positive health effects such as fetal brain development, insulin secretion, and reduced cancer risk. However, it also has been linked with some negative health outcomes such as cardiovascular disease and fatty liver disease. At the cellular level, 5-AVAB can influence cellular energy metabolism by reducing β-oxidation of fatty acids. This review will focus on the metabolic role of 5-AVAB with respect to both physiology and pathology. Moreover, the analytics and origin of 5-AVAB and related compounds will be reviewed. © 2022 The Authors
Author keywords5-aminovaleric acid betaine (5-AVAB); aminovaleric acid betaine; N,N,N-trimethyl-5-aminovalerate (TMAV); N,N,N-trimethyl-5-aminovaleric acid (TMAVA); δ-valerobetaine (δVB)
Ladattava julkaisu This is an electronic reprint of the original article. |